Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Chenghui Shuangda Pharmaceutical is a leading Chinese manufacturer of high-end APIs and advanced intermediates, supplying over 70 countries. The company produces APIs for local anesthetics, antivirals, cardiovascular and metabolic disease, oncology, digestive disease, diabetes, and veterinary indications, with several of its APIs registered in the US, EU, and China. It holds more than 200 patents and is recognized as a top-tier supplier for several products, such as articaine hydrochloride and vonoprazan fumarate, at commercial scale[1][3][5][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Chenghui Pharmaceutical.